HRA Pharma's emergency contraceptive gains FDA approval

08/15/2010 | Washington Post (tiered subscription model), The

The FDA approved HRA Pharma's ulipristal acetate, an emergency birth control pill that can prevent pregnancy as long as five days after unprotected sex. The contraceptive, which will be marketed as ella by Watson Pharmaceuticals, is expected to be available by year-end.

View Full Article in:

Washington Post (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC